Mandate

Vinge has advised Apoteket omstrukturering AB in connection with the sale of pharmacies

November 10, 2009

Vinge has advised Apoteket Omstrukturering AB in connection with the reregulation of the Swedish pharmacy market and in connection with the disposal through Apoteket AB (publ) of 8 so-called cluster companies consisting of a total of 465 pharmacies to Kronans Droghandel/KF, Altor, Priveq/Investor Growth Capital and Segulah for a total purchase price of approximately SEK 5.9 billion.

The Vinge team was led by Carl Gustaf De Geer and Henrik Wenckert and included associates from different practice areas such as M&A, Banking & Finance, EU &Antitrust, IT/Telecom, Employment & Benefits, Real Estate, Intellectual Property and also entailed regulatory issues regarding the pharmaceuticals legislation including licensing on the pharmacy market.

Related

Vinge advises Fidelio Capital in the divestment of a minority stake in Odevo to CVC Capital Partners

Vinge has advised Fidelio Capital (“Fidelio”) and the other shareholders of Odevo Group (“Odevo”) in connection with the divestment of a minority shareholding to funds controlled by CVC Capital Partners (“CVC”). Fidelio, the existing management team and other minority shareholders of Odevo will retain a majority holding in the company.
August 28, 2024

Vinge advises evroc in financing round

Vinge has advised Swedish evroc, which is planning to construct several large data centres in Europe and become a leading supplier of cloud services, to raise approximately SEK 500 million. The financing round participants include, among others, the previous investors EQT Ventures and Norrsken VC as well as the new investor Blisce, a French private equity firm.
August 22, 2024

Vinge advises Lunar Bank on the sale of its Swedish consumer loan portfolio to Morrow Bank

Vinge has advised Lunar Bank A/S on the sale of its approximately SEK 1.6 billion consumer loan portfolio to Morrow Bank ASA.
August 20, 2024